Literature DB >> 6409473

Defective monocyte function in pyoderma gangrenosum with IgG kappa paraproteinaemia.

R R Jones, A Kobza Black, M Donaghy, O Moshtael, A J Pinching.   

Abstract

Peripheral blood monocytes from a patient with pyoderma gangrenosum and paraproteinaemia showed defective phagocytosis; longitudinal observations demonstrated an association between the defect, the level of paraprotein and the clinical activity of the pyoderma. Treatment with Melphalan led to a reduction in the paraprotein level and remission of the pyoderma and was accompanied by normalization of monocyte function. After 8 months remission the paraprotein level rose again and was accompanied by a recurrence of the monocyte defect; shortly after this the pyoderma recurred. Pre-incubation of normal monocytes with the patient's plasma or immunoglobulin fractions revealed that a similar defect could be induced in normal cells by the patient's monomeric IgG. The patient's serum also had anti-heparin activity and the relationship between this and the phagocytic defect was explored. These studies indicate a possible pathogenetic mechanism underlying the association between pyoderma gangrenosum and monoclonal gammopathy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6409473      PMCID: PMC1536048     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  "Streaking leukocyte factor," arthritis, and pyoderma gangrenosum.

Authors:  J C Jacobs; E J Goetzl
Journal:  Pediatrics       Date:  1975-10       Impact factor: 7.124

2.  Suppression by IgA of IgG-mediated phagocytosis by human polymorphonuclear leucocytes.

Authors:  J M Wilton
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

Review 3.  The current status of pyoderma gangrenosum.

Authors:  P J Holt
Journal:  Clin Exp Dermatol       Date:  1979-12       Impact factor: 3.470

4.  Crystalline IgG protein in multiple myeloma: identification effects on coagulation and on lipoprotein metabolism.

Authors:  H I Glueck; M R MacKenzie; C J Glueck
Journal:  J Lab Clin Med       Date:  1972-05

5.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

6.  A raft technique for chemotaxis: a versatile method suitable for clinical studies.

Authors:  I E Addison; J W Babbage
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

7.  Pyoderma gangrenosum: a reappraisal of associated systemic diseases.

Authors:  J G Hickman; G S Lazarus
Journal:  Br J Dermatol       Date:  1980-02       Impact factor: 9.302

8.  Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis.

Authors:  P J Holt; M G Davies; K C Saunders; G Nuki
Journal:  Medicine (Baltimore)       Date:  1980-03       Impact factor: 1.889

9.  Pyoderma gangrenosum. Abnormal monocyte function corrected in vitro with hydrocortisone.

Authors:  D A Norris; W L Weston; G Thorne; J R Humbert
Journal:  Arch Dermatol       Date:  1978-06

10.  Suppression of leukocyte chemotaxis by human IgA myeloma components.

Authors:  D E Van Epps; R C Williams
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  1 in total

1.  A functional comparison of IIIindium-labelled elicited peripheral blood neutrophils and peritoneal neutrophils in the rat.

Authors:  J A Savige; S H Saverymuttu; A J Pinching
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.